CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-13 | Luly Jay R. President and CEO | Shares withheld for taxes | −20,591 | $52.77 | $1.1M | 819,810 |
| 2023-02-13 | Luly Jay R. President and CEO | Grant or award | +15,285 | 803,590 | ||
| 2023-02-13 | Luly Jay R. President and CEO | Grant or award | +16,220 | 819,810 | ||
| 2023-02-13 | Luly Jay R. President and CEO | Shares withheld for taxes | −20,591 | $52.77 | $1.1M | 799,219 |
| 2023-02-09 | MELLETT PAUL J Treasurer and CFO | Sale | −4,200 | $53.64 | $225K | 84,263 |
| 2023-02-09 | MELLETT PAUL J Treasurer and CFO | Sale | −800 | $54.41 | $44K | 83,463 |
| 2023-01-09 | MELLETT PAUL J Treasurer and CFO | Option exercise | +2,812 | $14.18 | $40K | 88,463 |
| 2023-01-09 | MELLETT PAUL J Treasurer and CFO | Option exercise · Stock Option (Right to Buy) | −2,812 | 0 | ||
| 2022-12-19 | MELLETT PAUL J Treasurer and CFO | Option exercise | +4,148 | $14.18 | $59K | 85,651 |
| 2022-12-19 | MELLETT PAUL J Treasurer and CFO | Option exercise · Stock Option (Right to Buy) | −4,148 | 0 | ||
| 2022-12-19 | Luly Jay R. President and CEO | Option exercise | +14,500 | $27.58 | $400K | 788,305 |
| 2022-12-19 | Luly Jay R. President and CEO | Option exercise · Stock Option (Right to Buy) | −14,500 | 55,500 | ||
| 2022-12-16 | Luly Jay R. President and CEO | Option exercise | +16,149 | $14.18 | $229K | 789,954 |
| 2022-12-16 | Luly Jay R. President and CEO | Option exercise | +13,851 | $14.00 | $194K | 803,805 |
| 2022-12-16 | Luly Jay R. President and CEO | Sale | −7,800 | $43.59 | $340K | 796,005 |
| 2022-12-16 | Luly Jay R. President and CEO | Sale | −8,597 | $44.54 | $383K | 787,408 |
| 2022-12-16 | Luly Jay R. President and CEO | Sale | −13,603 | $45.49 | $619K | 773,805 |
| 2022-12-16 | Luly Jay R. President and CEO | Option exercise · Stock Option (Right to Buy) | −16,149 | 0 | ||
| 2022-12-16 | Luly Jay R. President and CEO | Option exercise · Stock Option (Right to Buy) | −13,851 | 27,912 | ||
| 2022-12-01 | Luu Brendan Sr. VP, Business Dev. | Shares withheld for taxes | −498 | $44.33 | $22K | 25,725 |
Page 10 of 19 · 377 trades